Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581

Subjects

Subjects :

Androgen deprivation therapy, Neridronate, Bisphosphonates, Osteoporosis, Prostate cancer

Details

Language :

English

Database :

OpenAIRE

Accession number :

edsair.od......3978..39f44d39c8b10be9f182599bc9356d55